Torcetrapib Completed Phase 3 Trials for Dyslipidemia (Fredrickson Type Ⅱa) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00134511Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder